benefits of glp-1 agonists Medications: Everything You Need to Know What is GLP-1? Benefits, Uses
Description
Prolonged lipopolysaccharide-induced illness elevates glucagon-like peptide-1 and suppresses peptide YY: a human-randomized cross-over trial

Whilst diarrhea occurs in up to 20% of patients treated with GLP-1RA, 118 national registry studies from Denmark, 89 Israel, 92 and the USA, 93 collectively involving over 10 000 patients with IBD, found no indication that GLP-1RA use was associated with worsening of IBD symptoms or increased adverse event rates

Metabolism 2021;118:154728.ArticlePubMed 77

The USAs large diabetic population and the shift towards modern, effective diabetes treatments continue to drive the market for GLP-1 receptor agonists

Michielan A, D'Inc R

Prior serious hypersensitivity to a GLP-1 medication
